Health Care › Services-Commercial Physical & Biological Research

MXCT Stock Price Correlated With MaxCyte Financials

MXCT Stock Price vs. Quarterly

Enable JavaScript to see charts like this:

log linear

Income Statement

Cash Flow

Balance Sheet

MXCT Income Statement

Enable JavaScript and reload

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Gross Profit:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Income Taxes:

Net Income:

Earnings Per Share, Diluted:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

Shares Outstanding, Diluted Avg:

Common Stock Shares Outstanding:

MXCT Cash Flow

Enable JavaScript and reload

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Repurchases/Buybacks Common Stock:

Issuance of Long-term Debt:

Cash Dividends Paid:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Purchases of Businesses, Net of Cash:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

MXCT Balance Sheet

Enable JavaScript and reload

Cash and Cash Equivalents:

Short-Term Investments:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Long-Term Liabilities:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Blackrock.

6,920,084 sh

105,002 sh
2%

$31,763

-$37,178,585

Vitruvian Partners

5,043,356 sh

$23,149

Vanguard Group

4,970,930 sh

82,457 sh
2%

$22,816

-$1,381

Casdin Capital

4,715,000 sh

-210,000 sh
-4%

$21,642

-$2,737

Stonepine Capital Management

3,966,916 sh

3,693,629 sh
1352%

$18,208

$16,716

Arrowmark Colorado Holdings

2,576,260 sh

277,186 sh
12%

$11,825

$445

Holocene Advisors, Lp

2,117,228 sh

$9,718

Massachusetts Financial Services /Ma/

1,949,375 sh

-18,866 sh
-1%

$8,948

-$795

Millennium Management

1,936,992 sh

-910,161 sh
-32%

$8,891

$8,877

Granahan Investment Management/Ma

1,891,888 sh

1,183,731 sh
167%

$8,684

$5,179

Blue Water Life Science Advisors

1,885,000 sh

-1,340,000 sh
-42%

$8,652

-$7,312

First Light Asset Management

1,857,566 sh

493,344 sh
36%

$8,526

$1,773

State Street

1,812,374 sh

18,225 sh
1%

$8,319

-$562

Geode Capital Management

1,794,652 sh

115,276 sh
7%

$8,237

-$76

American Century Companies

1,708,861 sh

23,670 sh
1%

$7,844

-$480

Portolan Capital Management

1,649,877 sh

1,028,263 sh
165%

$7,573

$4,496

Morgan Stanley

1,622,017 sh

-58,852 sh
-4%

$7,445

-$875

River & Mercantile Asset Management Llp

1,542,743 sh

-165,605 sh
-10%

$7,031

-$1,374

Grandeur Peak Global Advisors

1,378,548 sh

186,743 sh
16%

$6,328

-$179

Ameriprise Financial

1,319,739 sh

-9,826 sh
-1%

$6,058

-$523

Free historical financial statements for MaxCyte Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 9 quarters since 2021. Compare with MXCT stock chart to see long term trends.

Data imported from MaxCyte Inc. SEC filings. Check original filings before making any investment decision.